Skip to content
nutrition — Mental-health — Irreversible — Fitness-and-exercise — Symptoms — Science — Antibiotic — Health-and-wellness — Medical-conditions — Tb — Adherence — Chronic-diseases

Significant numbers of tuberculosis survivors in South Africa grapple with lasting lung damage, according to medical professionals.

In South Africa, over 3 million individuals previously diagnosed with TB have been successfully treated and have recovered. However, a troubling number of these individuals continue to experience long-term consequences from the illness.

,   and  Administrator
2 min read
Over three million South African individuals have successfully overcome TB. Regardless, numerous...
Over three million South African individuals have successfully overcome TB. Regardless, numerous survivors still grapple with the lingering consequences of the illness.

Significant numbers of tuberculosis survivors in South Africa grapple with lasting lung damage, according to medical professionals.

Slim-Down Consequences of Post-TB Lung Ailments

Post-Tuberculosis (TB) respiratory issues can leave a lasting impact, particularly in nations like South Africa, battling an ongoing TB epidemic. The impact includes:

  • Persistent Respiratory Symptoms: Cough, wheezing, and breathlessness remain common issues. Lung function tests often reveal impairment, such as airflow obstruction and restriction.[1][3][4]
  • Lung Damage: Imaging often reveals lung damage, like fibrosis and bronchiectasis, which can lead to lifelong respiratory failure.[1][3]
  • Declining Quality of Life: Individuals who have survived pulmonary TB often score low on health-related quality of life (HRQoL) due to persistent symptoms and functional impairments.[4]
  • Health Complications: Long-term complications may include severe cases necessitating intensive care, pleural effusions, and potentially life-threatening conditions like hemoptysis.[3]

Coping with Post-TB Respiratory Ailments

Effective management of Post-TB lung diseases (PTLD) involves a mix of medications, support, and surgical intervention:

  • Medical Approach: Symptoms and complications are managed with medicines like bronchodilators for airflow obstruction and antimicrobial therapy for secondary infections.[4]
  • Oxygen Assistance and Ventilation: Patients with respiratory failure may require oxygen therapy and mechanical ventilation.[3]
  • Surgical Procedures: In severe cases, such as hemoptysis or empyema, surgeries like bronchial artery embolization may be necessary.[3]
  • Preventive Strategies: Potentially, integrating new drugs, such as navitoclax, into TB treatment regimens could reduce lung scarring and improve outcomes by shortening treatment duration and minimizing complications.[2]

Novel Therapy Options

Research into innovative therapies like navitoclax touts the potential for reducing lung scarring and shortening TB treatment durations. This could be particularly beneficial in nations like South Africa, with high TB prevalence, where reduced treatment duration could boost adherence and outcomes.[2]

Battlefields and Opportunities in South Africa

In South Africa, managing PTLD is further complicated by high TB prevalence, HIV co-infection, and financial constraints. Overcoming these obstacles calls for:

  • Comprehensive Care Approach: This includes emotional support, managing comorbidities such as HIV to enhance treatment adherence and quality of life.
  • Advanced Diagnostic Access: Making use of advanced imaging techniques, such as PET scans, to monitor disease progression and treatment response.
  • Public Health Initiatives: Improving tuberculosis control via vaccination, contact tracing, and community-based programs.

By tackling these aspects, South Africa can improve long-term care and outcomes for individuals dealing with PTLD.

  1. Post-TB lung ailments can lead to irreversible respiratory failure due to damage like fibrosis and bronchiectasis, as revealed by imaging.
  2. Effective management of Post-TB lung diseases (PTLD) involves medication, such as antibiotics for secondary infections and bronchodilators for airflow obstruction.
  3. Advanced diagnostic access, like the use of PET scans, can help monitor disease progression and treatment response in individuals dealing with PTLD.
  4. Comprehensive care, including emotional support and management of comorbidities such as HIV, enhances treatment adherence and quality of life for those dealing with PTLD.
  5. Research into innovative therapies, like navitoclax, suggests the potential for reducing lung scarring and shortening TB treatment durations, which could boost adherence and outcomes, particularly in high-prevalence regions like South Africa.
  6. Improving tuberculosis control via vaccination, contact tracing, and community-based programs can help address challenges in nations like South Africa, where managing PTLD is complicated by high TB prevalence, HIV co-infection, and financial constraints.

Read also:

    Related

    Latest